Breast Cancer Clinical Trials in Phoenix

Showing 381-400 of 552 trials

Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy

NCT03201913

Phase1 study of TTC 352 for treatment of metastatic ER+ breast cancer.

TTC Oncology, LLC15 participantsStarted Dec 2017

Scottsdale, Arizona, United States • Saint Paul, Minnesota, United States • Sioux Falls, South Dakota, United States +1 more locations

COMPLETEDPhase 111 miles

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

NCT02223052

This is a Phase 1, open-label, multicenter, randomized, 2-stage crossover study consisting of 2 phases: Stage I - Pharmacokinetics (Bioequivalence), with an Extension Stage II - Pharmacokinetics (Food Effect) with an Extension This study will enroll approximately 60 subjects in stage I and 60 subjects in stage II with hematologic or solid tumor malignancies, excluding gastrointestinal tumors and tumors that have originated or metastasized to the liver for which no standard treatment exists or have progressed or recurred following prior therapy. Subjects must not be eligible for therapy of higher curative potential where an alternative treatment has been shown to prolong survival in an analogous population. Approximately 23 sites in the US and 2 in Canada will participate in this study.

Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more

Celgene89 participantsStarted Oct 2014

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +7 more locations

Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Breast Cancer Trials in Other Cities

Combination Chemotherapy in Treating Patients With Breast Cancer

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

Exercise Preconditioning and Breast Cancer Cardiotoxicity

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer

A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer

A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body

Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer

A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide

MRI to Detect Breast Tumors in Women

Vaccine Therapy in Treating Patients With Breast Cancer

Other Conditions in Phoenix